<?xml version="1.0" encoding="UTF-8"?>
<p>The results of each compound were reported in 
 <xref rid="tab6" ref-type="table">Table 6</xref>. The results show the contacts of LC
 <sub>50</sub>, TGI, and GI
 <sub>50</sub> values. The compound 1a (GI
 <sub>50</sub> = 0.69
 <italic>μ</italic>M) was high, while Cu-Nps-Pyr-1a (GI
 <sub>50</sub> = 0.01 
 <italic>μ</italic>m) showed a significant activity against the HeLa cancer cell line. The compound 1b (GI
 <sub>50</sub> = 02.1 
 <italic>μ</italic>M) and Cu-Nps-Pyr-1b (GI
 <sub>50</sub> = 0.01 
 <italic>μ</italic>M) showed rightful activity against the HepG2 cell line compared with standard doxorubicin. All compounds displayed a moderate activity against all the cell line, whereas when compound with Cu nanoparticles, it is becoming highly responsive in cytotoxic scanning.
</p>
